AI assistant
ABBOTT LABORATORIES — Board/Management Information 2012
May 2, 2012
29777_rns_2012-05-02_435ae95b-59f9-427f-9526-67d5a0b6e6a1.zip
Board/Management Information
Open in viewerOpens in your device viewer
8-K 1 a12-10878_28k.htm 8-K
*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*
*WASHINGTON, D.C. 20549*
*FORM 8-K*
*CURRENT REPORT*
*Pursuant to Section 13 or 15(d) of the*
*Securities Exchange Act of 1934*
Date of Report (Date of earliest event reported): April 27, 2012
*Abbott Laboratories*
(Exact name of registrant as specified in its charter)
| Illinois | 1-2189 | 36-0698440 |
|---|---|---|
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
*100 Abbott Park Road*
*Abbott Park, Illinois 60064-6400*
(Address of principal executive offices)(Zip Code)
Registrants telephone number, including area code: (847) 937-6100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SEQ.=1,FOLIO='',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'
*Item 5.02 Departure of Directors or Certain Officers.*
Edward L. Michael, Executive Vice President, Diagnostics Products, has informed Abbott that he will be retiring from the company within the next couple of months.
2
SEQ.=1,FOLIO='2',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'
*SIGNATURE*
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/ Thomas C. Freyman |
|---|
| Thomas C. Freyman |
| Executive Vice President, Finance and Chief Financial Officer |
3
SEQ.=1,FOLIO='3',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'